Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Plasmatech Biopharma, Inc. (PTBI) Starts Presentation at 2015 Marcum MicroCap Conference

Posted on May 28, 2015 by MissionIR

PlasmaTech Biopharmaceuticals is a biopharmaceutical company in the business of developing protein biologic therapies and oncology supportive care products. The company’s products are MuGard for the management of oral mucositis and ProctiGard for the treatment of radiation proctitis, a frequent side effect of radiation treatment to the pelvic region. It also develops CobaCyte, a mediated targeted delivery technology that has application in in tumor targeting. For more information, visit the company website at www.plasmatechbio.com

The Marcum MicroCap Conference is a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The two-day 2016 conference will include feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders, and the opportunity to meet with management of presenting companies on a one-on-one basis. Marcum is partnered with KCSA Strategic Communications to present this year's Marcum MicroCap Conference.
This entry was posted in Marcum MicroCap. Bookmark the permalink.

Comments are closed.